Latest common stock for CMRAW: $2.8K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (September 2023), CMRAW shows a common stock of $2.8K. That compares with $1.7K in the prior-year period — up 65.7% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CMRAW's common stock is now $2.8K (was $1.7K) — a 65.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Comera Life Sciences Holdings- Warrants (19/05/2027) is outperforming or lagging.
Tracking CMRAW's common stock over time shows whether Comera Life Sciences Holdings- Warrants (19/05/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.8K That compares with $1.7K in the prior-year period — up 65.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Comera Life Sciences Holdings- Warrants (19/05/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $2.8K) with ownership activity and broader fundamentals.